Royal Bank of Canada’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37K | Buy |
3,691
+3,649
| +8,688% | +$36.6K | ﹤0.01% | 5663 |
|
|
2025
Q1 | $3K | Buy |
42
+34
| +425% | +$2.43K | ﹤0.01% | 6078 |
|
|
2024
Q4 | $1K | Sell |
8
-51
| -86% | -$6.38K | ﹤0.01% | 6258 |
|
|
2024
Q3 | $4K | Buy |
59
+23
| +64% | +$1.56K | ﹤0.01% | 6066 |
|
|
2024
Q2 | $2K | Buy |
36
+28
| +350% | +$1.56K | ﹤0.01% | 6313 |
|
|
2024
Q1 | $8K | Sell |
8
-91
| -92% | -$91K | ﹤0.01% | 5822 |
|
|
2023
Q4 | $79K | Buy |
99
+59
| +148% | +$47.1K | ﹤0.01% | 5217 |
|
|
2023
Q3 | $19K | Buy |
40
+15
| +60% | +$7.13K | ﹤0.01% | 5694 |
|
|
2023
Q2 | $15K | Buy |
25
+10
| +67% | +$6K | ﹤0.01% | 5862 |
|
|
2023
Q1 | $10K | Sell |
15
-28
| -65% | -$18.7K | ﹤0.01% | 5915 |
|
|
2022
Q4 | $44K | Buy |
43
+30
| +231% | +$30.7K | ﹤0.01% | 5487 |
|
|
2022
Q3 | $8K | Buy |
13
+12
| +1,200% | +$7.39K | ﹤0.01% | 6021 |
|
|
2022
Q2 | $1K | Sell |
1
-22
| -96% | -$22K | ﹤0.01% | 6618 |
|
|
2022
Q1 | $15K | Sell |
23
-42
| -65% | -$27.4K | ﹤0.01% | 6262 |
|
|
2021
Q4 | $26K | Buy |
65
+29
| +81% | +$11.6K | ﹤0.01% | 6141 |
|
|
2021
Q3 | $27K | Buy |
+36
| New | +$27K | ﹤0.01% | 5991 |
|